Poor countries to get new AIDS pill

Jul 06, 2006

A new 3-in-1 AIDS pill made in India and approved by U.S. drug regulators is expected to treat patients in poor countries.

The pill made by an Indian generic drug company is the first such antiretroviral treatment approved by the Food and Drug for patients in countries helped by the President's Emergency Plan for AIDS Relief, reports The New York Times.

Dr. Mark R. Dybul, the White House global AIDS coordinator, said the new pill should greatly improve treatment for patients in poor countries.

Under a White House plan, the United States has become the largest provider of antiretroviral drugs in the world. The plan helps treat some 561,000 patients in Africa, Asia and the Caribbean, the Times reported.

The new pill, made by Aurobindo Pharma of Hyderabad, India, combines three common first-line drugs, AZT, 3TC and NVP, which are sold in the United States as Retrovir, Epivir and Viramune, the report said.

Copyright 2006 by United Press International

Explore further: Expert highlights research innovation and is optimistic about the future of IBS treatment

add to favorites email to friend print save as pdf

Related Stories

New insights into placebo effect

Aug 31, 2012

(Phys.org)—Mathematical models developed by scientists at the University of Bristol are providing new insights into why the placebo effect exists and when it should occur. Their research is published today ...

NFC aid for the visually and hearing impaired

Feb 09, 2012

As the proportion of senior citizens grows, their special needs are gaining momentum. Human eyesight, for example, weakens with age. VTT Technical Research Centre of Finland has been developing new NFC-based applications ...

30 years after first AIDS cases, hope for a cure

Jun 03, 2011

(AP) -- Sunday marks 30 years since the first AIDS cases were reported in the United States. And this anniversary brings fresh hope for something many had come to think was impossible: finding a cure.

Revisiting ADHD and Ritalin

May 17, 2011

Fifteen years ago, Dr. Lawrence H. Diller, a pediatrician from Walnut Creek, Calif., ignited a national debate over the steep rise in children being diagnosed with attention-deficit hyperactivity disorder and treated with ...

Team identifies new colon cancer marker

Mar 25, 2011

A research team at the University of Colorado Cancer Center has identified an enzyme that could be used to diagnose colon cancer earlier. It is possible that this enzyme also could be a key to stopping the cancer.

Recommended for you

Alternate approach to traditional CPR saves lives

2 hours ago

A new study shows that survival and neurological outcomes for patients in cardiac arrest can be improved by adding extracorporeal membrane oxygenation (ECMO) when performing cardiopulmonary resuscitation (CPR). The study ...

User comments : 0